Michael N. Gwynn
South College(US)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Cancer therapeutics and mechanisms, Microbial Natural Products and Biosynthesis, Antibiotics Pharmacokinetics and Efficacy, Plant biochemistry and biosynthesis
Most-Cited Works
- → Drugs for bad bugs: confronting the challenges of antibacterial discovery(2006)2,470 cited
- → Type IIA topoisomerase inhibition by a new class of antibacterial agents(2010)819 cited
- → Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance(2010)303 cited
- → Identification, Evolution, and Essentiality of the Mevalonate Pathway for Isopentenyl Diphosphate Biosynthesis in Gram-Positive Cocci(2000)261 cited
- → Challenges of antibacterial discovery revisited(2010)191 cited
- → Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin(2015)155 cited
- → Novel Chromosomally Encoded Multidrug Efflux Transporter MdeA in Staphylococcus aureus(2004)146 cited
- → Essentiality, Expression, and Characterization of the Class II 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase of Staphylococcus aureus(2000)80 cited
- → Genetic Characterization of Vga ABC Proteins Conferring Reduced Susceptibility to Pleuromutilins in Staphylococcus aureus(2008)70 cited
- → Enterococcus faecalis Acetoacetyl-Coenzyme A Thiolase/3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase, a Dual-Function Protein of Isopentenyl Diphosphate Biosynthesis(2002)70 cited